THE 6TH BALTIC SUMMER SCHOOL:

 

DIABETES
molecular heterogeneity, mechanisms and emerging technologies

Place and time
22.08 - 03.09, Theoretical Course, University of Lund
03.09 - 10.09, Laboratory Course, Universities of Lund, Kiel and Copenhagen.

Participation fee
250 EURO. The participation fee covers lunches as well as course material.

Baltic Summer School Stipends
Stipend covers accommodation and some living expenses. Travel expenses (cheapest airfare) may also
be supported on an individual basis. All participants are eligible for stipends, no specific application is required.

Application deadline
Friday, April 30, 2004. Notice of acceptance of applications by Monday, May 24, 2004.

PLEASE MAKE SURE YOU RECEIVE AN ACKNOWLEDGEMENT OF RECEIPT OF APPLICATION .

The Theoretical Course, 22.08-03.09, at the University Hospital MAS, Malmö, Sweden, is open
to 50 young scientists at the late phase of their PhD studies as well as at the medical specialist or post-doc levels. The Faculty Members of the Baltic Summer School, with co-ordinating professor Åke Lernmark, includes worldwide experts who will present the current knowledge within the following fields:

· Epidemiology, genetics, diagnostic criteria and classification Beta Cell Development and stem
Cells as well as pro-inflammation and autoimmunity, pathophysiology and degeneration
· The Exo-Endo Axis of the Pancreas and pancreatic disorders
· Insulin action and the development of diabetes and its complications
· Diabetes Prediction and Prevention
· Cytokines in Immune and Metabolic Function

Invited speakers will participate in panel discussions. There will be opportunities for poster presentations and workshops on research opportunities and funding mechanisms.

The Laboratory Course, 03.09-10.9, Lund, Kiel and Copenhagen is open to 20 of the young scientists participating in the theoretical course, who will join on-going research projects ranging from molecular mechanisms of insulin secretion and action, metabolism, diabetes etiology and pathogenesis including autoimmunity of type 1 diabetes to clinical research and mangement skills in diabetes. Special emphasis
is on the heterogeneity of diabetes and molecular mechanisms of disease development and differential diagnosis.

 

 

 
Back